CXCL13 also occurs in CNS inflammation and is the focus of biomarker research for Lyme neuroborreliosis (LNB), CNS lymphoma, and multiple sclerosis (MS) [8]. This evidence concerns the gene CXCL13 and myeloid sarcoma.